According to FMI estimates, the net worth of total cold plasma to be sold globally could generate USD 2469.5 million in revenue in 2023. Furthermore, the global cold plasma market size is expected to increase to USD 9380.9 million by 2033 at a CAGR of 14.3%.
Cold plasma care portable device has been extensively used across the medicinal, bioengineering, and food processing sectors. Several applications across the life sciences domain have also been recorded for atmospheric pressure cold plasma applications.
Healthcare practitioners are incorporating cold plasma for treating traumatic and surgical wounds. These widespread applications are increasingly expanding the scope of the cold plasma systems market. It is anticipated to grow staggeringly at an annual rate of 14.3% throughout the years between 2023 and 2033.
Atmospheric pressure cold plasma applications market players employ electricity and carrier gas, mostly helium, oxygen, or nitrogen. A wide range of cold plasma systems operating at atmospheric pressures is under development which is expected to strengthen the market further.
| Attributes | Details |
|---|---|
| Cold Plasma Market Share (2022) | USD 2164.7 million |
| Cold Plasma Market Size Value (2023) | USD 2469.5 million |
| Cold Plasma Market Size Value (2033) | USD 9380.9 million |
| Cold Plasma Market Growth Rate (2023 to 2033) | 14.3% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As per the earlier market survey reports, the net valuation of the global cold plasma business was USD 1,144.2 million back in the year 2017. In the following years, progress in the adoption of cold plasma systems followed an impressive CAGR while experiencing an uptick during the pandemic years.
However, growth prospects across other verticals were significantly hindered, particularly in the textile, food processing, electronics manufacturing, and polymer industries.
This shot-turn downturn was attributed to the decline in industrial production due to lockdowns imposed by governments to flatten the infection curve. This sluggishness in demand for cold plasma remained prevalent until the latter half of 2022 bringing down the annual average growth rate to 13.6%.
Principal Consultant
Need for In-Package Decontamination Up scales Cold Plasma Adoption by Food & Beverage Industries
Over the years, food contamination has become a major cause of concern. This ranges from the prevalence of harmful microbes to abnormally high concentrations of inorganic chemicals during the processing, packaging, transportation, and storage phases.
As a result, food items need to be thoroughly inspected and measured, requiring several plasma testing approaches. Amongst all food decontamination procedures, cold plasma promises to deliver the most favorable results. The testing duration ranges anywhere between 3 seconds to 120 seconds, making it the fastest testing method among all procedures.
Advancements in the plasma tube systems have opened up new frontiers for the in-vivo reduction of food-borne pathogens. Such successes are motivating manufacturers to develop food-grade cold plasma testing kits, anticipated to generate credible market expansion opportunities during the upcoming decade.
Atmospheric Pressure Cold Plasma Applications Proliferate in Chronic Wounds Treatment
Since 2005, applications in cancer treatment, dentistry, and wound healing have been extensively explored across several laboratories, research centers, academic institutions, and healthcare settings. These have largely translated into seminal publications, case studies, and educational programs on cold plasma applications.
Significant work has been done by the German start-up company Terraplasma Medical in the field of biomedical-grade cold plasma. It markets the Plasma Care portable device which produces cold plasma to kill pathogens accumulated in chronic wounds. The company acquired a CE mark approval for this hand-held device in 2019.
Immense Breakthroughs in Cancer Diagnostics to Steer Higher Adoption of Cold Plasma Therapies
In 2019, a multi-institute team led by Purdue University aerospace engineer Alexey Shashurin developed a pen-shaped electrosurgical scalpel that sprays a blue jet of cold plasma on any leftover cancerous tissues or cells for nearly 2 to 7 minutes. The device is equipped to target only malignant tissues, leaving healthy ones intact.
The results were announced through a series of in vitro, in vivo, and FDA-approved compassionate use cases initiated prior to the actual clinical trials. The clinical trials have been sponsored by the United States Medical Innovations LLC and Jerome Canady Research Institute for Advanced Biological and Technological Sciences.
| Attributes | Details |
|---|---|
| United States Market Size (2033) | USD 2809.5 million |
| United States Absolute Dollar Growth | USD 5.7 million |
| United States Market CAGR (2023 to 2033) | 13.7% |
Heightened adoption in food safety determination and decontamination is primarily driving the North American cold plasma market. The region emerged as the market hegemon in 2019 and is poised to continue demonstrating this trend throughout the forecast period. Within North America, the United States is anticipated to project the strongest trends, while Canada may witness a higher adoption of cold plasma technology.
| Attributes | Details |
|---|---|
| Canada Market Size (2033) | USD 386.8 million |
| Canada Absolute Dollar Growth | USD 14.1 million |
| Canada Market CAGR (2023 to 2033) | 15.9% |
| Attributes | Details |
|---|---|
| Germany Market Size (2033) | USD 609.3 million |
| Germany Absolute Dollar Growth | USD 17.5 million |
| Germany Market CAGR (2023 to 2033) | 13.4% |
Europe is anticipated to register a prolific increase in the cold plasma market, attributed to heightened demand for decontaminated frozen food, and rising polymer production. Germany is the leading region in Europe owing to the increased adoption of cold plasma for textile production, and other high-value industries.
| Attributes | Details |
|---|---|
| United Kingdom Market Size (2033) | USD 463.6 million |
| United Kingdom Absolute Dollar Growth | USD 17.5 million |
| United Kingdom Market CAGR (2023 to 2033) | 13.6% |
| Attributes | Details |
|---|---|
| China Market Size (2033) | USD 628.1 million |
| China Absolute Dollar Growth | USD 22.7 million |
| China Market CAGR (2023 to 2033) | 15.8% |
A large population base in the Asia Pacific countries entails heightened cases of several health ailments. Consequently, hospital admissions have increased.
This increase in hospital admissions has also elevated the risk of contracting nosocomial infections, for which cold plasma disinfection would experience tremendous scope.
The majority of this demand is expected to be stimulated by emerging economies such as China and India. Global vendors in the cold plasma sector are therefore scrambling to acquire a foothold in these regions.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Attributes | Details |
|---|---|
| Top Regime Type | Atmospheric Pressure |
| CAGR % 2017 to 2022 | 14.7% |
| CAGR % 2023 End of Forecast (2033) | 13.4% |
Experts have concluded that cold atmospheric plasma treatment can make significant inroads in the treatment of coronavirus-positive patients in the forthcoming time period. Several anesthesiologists, microbiologists, and virologists are exploring this possibility. Precedents have established that cold plasma disinfection can deactivate air-borne pathogens, including some potentially deadly viruses.
A study conducted by the University of Michigan discovered that employing a non-thermal plasma reactor could eradicate 99.9% of the virus in the airstream through inactivation. This example renders it prudent to suppose that the novel coronavirus strain may also be inactivated by cold plasma, thus eventually providing a potential cure for viral diseases.
| Attributes | Details |
|---|---|
| Top Application | Wound Healing |
| CAGR % 2017 to 2022 | 14% |
| CAGR % 2023 End of Forecast (2033) | 12.9% |
Chronic wounds such as diabetic ulcers, either heal with great difficulty or not at all, rendering them susceptible to infections from external bacteria and other pathogens. In this regard, cold plasma has proven highly beneficial. It is capable of inactivating bacteria such as methicillin-resistant Staphylococcus aureus (MRSA), the key infecting pathogens.
Cold plasma disinfection is also acquiring momentum with respect to prolonging the lives of personal protective gear. Due to the shortage of protective and sterile clothing, healthcare providers are treating existing gear with cold plasma, effectively inactivating any pathogen which may be present on the surface.
In 2019, the Electronics & Photonic Innovation Center (EPIC) acquired a substantial number of United Kingdom-based Henniker Plasma’s HPT-200 plasma treatment systems. It helped in expanding their own business capabilities and created awareness about technological advancements in the electronics & photonics industry.
In 2020, German company Plasmatreat deployed a prototype cleaning station in conjunction with the Bavarian Red Cross for disinfecting single-use protective clothing. It was for frontline COVID-19 healthcare workers while another station is currently undergoing clinical testing in the University Hospital at the Technical University of Munich.
In February 2020, Adtech Plasma Technology initiated a new project in collaboration with Hull York Medical School for testing gas plasma on osteomyelitis bone infections. The project is expected to assist in establishing a laboratory testing model for evaluating and optimizing plasma treatment for osteomyelitis biofilm infections.
In 2019, Europlasma NV launched PlasmaGuard, the first all-halogen-free plasma-enhanced chemical vapor deposition (PECVD) conformal coating for printed circuit boards and wearable devices. Its sister company, CPI, developed a proprietary plasma technology that helps protect the environment by reducing CO2 output through reduced energy generation.
Thierry Corporation is yet another important player, which not only offers several plasma cleaning technologies but also provides pre-sales, sales, and after-sales services to its clients, allowing it to acquire a significant competitive edge over its rivals.
The market has the potential to be estimated at US$ 2469.5 million in 2023.
From 2018 to 2022, sales developed considerably at a 13.6% CAGR.
The market to steadily expand at a 14.3% CAGR through 2033.
By 2033, the global market is expected to be worth US$ 9380.9 million.
The United States market is set to expand at a CAGR of 13.7% through 2033.
1. Executive Summary | Cold Plasma Market 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Regime Type 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 6.3.1. Would Healing 6.3.2. Cancer Treatment 6.3.3. Blood Coagulation 6.3.4. Dentistry 6.3.5. Packaging Decontamination 6.3.6. Food Surface Decontamination 6.3.7. Wastewater Treatment 6.3.8. Seed Germination 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Technology 7.3.1. Remote Treatment 7.3.2. Direct Treatment 7.3.3. Electrode Contact 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 8.3.1. Medical Industry 8.3.2. Textile Industry 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. Asia Pacific 9.3.5. Middle East and Africa 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. Key Countries Market Analysis 16. Market Structure Analysis 17. Competition Analysis 17.1.1. Linde AG 17.1.2. Nordson Corporation 17.1.3. ADTEC Plasma Technology Co., Ltd. 17.1.4. Bovie Medical Corporation 17.1.5. Europlasma NV 17.1.6. Henniker Plasma 17.1.7. Vetaphone A/S 17.1.8. Plasmatreat GmbH 17.1.9. Neoplas Tools GmbH 17.1.10. Ethicon, Inc. 17.1.11. Baxter International 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports
Cold Plasma Market
